The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis

BACKGROUND: The use of a combination of the integrase inhibitor, cabotegravir, and the non-nucleoside reverse transcriptase inhibitor, rilpivirine, in a long-acting injectable form is being considered as an antiretroviral treatment option for people with HIV in sub-Saharan Africa. We aimed to model...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Andrew N, Bansi-Matharu, Loveleen, Cambiano, Valentina, Ehrenkranz, Peter, Serenata, Celicia, Venter, Francois, Pett, Sarah, Flexner, Charles, Jahn, Andreas, Revill, Paul, Garnett, Geoff P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050198/
https://www.ncbi.nlm.nih.gov/pubmed/33770513
http://dx.doi.org/10.1016/S2214-109X(21)00025-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050198/
https://www.ncbi.nlm.nih.gov/pubmed/33770513
http://dx.doi.org/10.1016/S2214-109X(21)00025-5

Ejemplares similares